Category: ODD/BTA/FTA Status Region: North America · United States Company: Stealth Bio Therapeutics Inc

FDA grants orphan drug designation to elamipretide for LHON

FDA grants orphan drug designation to elamipretide for LHON
The FDA granted Orphan Drug Designation to elamipretide, for the treatment of Leber

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!